TNFSF10 and cancer: A member of the TNF family of cytokines, TNF-related apoptosis-inducing ligand (TRAIL) was first discovered for its ability to kill human cancer cells upon ligation with its signalling receptors, namely, death receptor-4 and -5 (DR4 and DR5), without affecting normal cells [4,5].